Home > Insider Trading > Filing (0001209191-15-050089)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221041	A Sarah Oconnor	Elizabeth House, 9 Castle Street St Helier Y9 JE2 3RT		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2015-06-02	10,000	$15.50	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Ordinary Share Option (right to buy)	$9.26		2024-08-05	10,800	10,800	Direct
Ordinary Shares	Ordinary Share Option (right to buy)	$9.95		2024-10-31	5,025	5,025	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-08-05	10,800	10,800	Direct
2024-10-31	5,025	5,025	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.26 to $16.00, inclusive. The Reporting Person undertakes to provide Quotient Ltd. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The options vest and become exercisable in three equal annual installments beginning August 5, 2015.
1,675 options vested on 10/31/2014 and remain exercisable, 1,675 options will vest on 10/31/2015, 1,675 options will vest on 10/31/2016.